Cheminformatics Analysis of Assertions Mined from Literature That Describe Drug-Induced Liver Injury in Different Species
Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 c...
        Saved in:
      
    
          | Published in | Chemical research in toxicology Vol. 23; no. 1; pp. 171 - 183 | 
|---|---|
| Main Authors | , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        United States
          American Chemical Society
    
        01.01.2010
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0893-228X 1520-5010 1520-5010  | 
| DOI | 10.1021/tx900326k | 
Cover
| Abstract | Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39−44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds’ chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure−activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data. | 
    
|---|---|
| AbstractList | Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data. Drug Induced Liver Injury (DILI) is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structure is critical to help guiding experimental drug discovery projects towards safer medicines. In this study, we have compiled a dataset of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and non-rodents. The liver effects for this dataset were obtained as assertional meta-data, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this dataset using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39–44%) between different species raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion re-generation from MEDLINE, as well as other data sources. In some cases, additional biological assertions were identified which were in line with expectations based on compounds' chemical similarity. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs. no liver effect), and binary QSAR models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external five-fold cross validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data. Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39-44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds' chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure-activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data. Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental drug discovery projects toward safer medicines. In this study, we have compiled a data set of 951 compounds reported to produce a wide range of effects in the liver in different species, comprising humans, rodents, and nonrodents. The liver effects for this data set were obtained as assertional metadata, generated from MEDLINE abstracts using a unique combination of lexical and linguistic methods and ontological rules. We have analyzed this data set using conventional cheminformatics approaches and addressed several questions pertaining to cross-species concordance of liver effects, chemical determinants of liver effects in humans, and the prediction of whether a given compound is likely to cause a liver effect in humans. We found that the concordance of liver effects was relatively low (ca. 39−44%) between different species, raising the possibility that species specificity could depend on specific features of chemical structure. Compounds were clustered by their chemical similarity, and similar compounds were examined for the expected similarity of their species-dependent liver effect profiles. In most cases, similar profiles were observed for members of the same cluster, but some compounds appeared as outliers. The outliers were the subject of focused assertion regeneration from MEDLINE as well as other data sources. In some cases, additional biological assertions were identified, which were in line with expectations based on compounds’ chemical similarities. The assertions were further converted to binary annotations of underlying chemicals (i.e., liver effect vs no liver effect), and binary quantitative structure−activity relationship (QSAR) models were generated to predict whether a compound would be expected to produce liver effects in humans. Despite the apparent heterogeneity of data, models have shown good predictive power assessed by external 5-fold cross-validation procedures. The external predictive power of binary QSAR models was further confirmed by their application to compounds that were retrieved or studied after the model was developed. To the best of our knowledge, this is the first study for chemical toxicity prediction that applied QSAR modeling and other cheminformatics techniques to observational data generated by the means of automated text mining with limited manual curation, opening up new opportunities for generating and modeling chemical toxicology data.  | 
    
| Author | Tropsha, Alexander Bradley, Paul Barnes, Julie C Fourches, Denis Day, Nicola C Reed, Jane Z  | 
    
| AuthorAffiliation | 2 BioWisdom Ltd, Harston Mill, Harston, Cambridge, CB22 7GG, U.K 1 Laboratory for Molecular Modeling, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill NC 27599, USA  | 
    
| AuthorAffiliation_xml | – name: 2 BioWisdom Ltd, Harston Mill, Harston, Cambridge, CB22 7GG, U.K – name: 1 Laboratory for Molecular Modeling, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill NC 27599, USA  | 
    
| Author_xml | – sequence: 1 givenname: Denis surname: Fourches fullname: Fourches, Denis – sequence: 2 givenname: Julie C surname: Barnes fullname: Barnes, Julie C – sequence: 3 givenname: Nicola C surname: Day fullname: Day, Nicola C – sequence: 4 givenname: Paul surname: Bradley fullname: Bradley, Paul – sequence: 5 givenname: Jane Z surname: Reed fullname: Reed, Jane Z – sequence: 6 givenname: Alexander surname: Tropsha fullname: Tropsha, Alexander email: alex_tropsha@unc.edu  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20014752$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNptkU1vEzEQhi1URNPCgT-AfEGIw1J_7Nq7F6Qo4SNSEAeKxM1yvOPGYddObW9F_j2uUiJAPc1I88w7H-8FOvPBA0IvKXlHCaNX-VdHCGfi5xM0ow0jVUMoOUMz0na8Yqz9cY4uUtoRQgsun6FzVtJaNmyGDostjM7bEEednUl47vVwSC7hYPE8JYjZBZ_wF-ehxzaGEa9dhqjzFAFfb3XGS0gmug3gZZxuqpXvJ1PQtbuDiFd-N8UDdh4vnbUQwWf8bQ_GQXqOnlo9JHjxEC_R948frhefq_XXT6vFfF1pLrpcSS3bum7rzlDWG0G7VsjayI4I0fGNbY2UwkLLNTFy05OGCcaM6HpTLqyt6fglen_U3U-bEXpTVoh6UPvoRh0PKmin_q14t1U34U6xtryRsiLw5kEghtsJUlajSwaGQXsIU1KS85Y0vK4L-ervUacZf95dgLdHwMSQUgR7QihR91aqk5WFvfqPNS7rezfKlm54tOP1sUObpHZhisXK9Aj3G4kmrjo | 
    
| CitedBy_id | crossref_primary_10_1111_j_1747_0285_2012_01411_x crossref_primary_10_1080_08927022_2024_2365377 crossref_primary_10_1007_s11224_012_0195_8 crossref_primary_10_1016_j_compbiomed_2013_11_013 crossref_primary_10_1007_s11030_012_9364_3 crossref_primary_10_1080_00268976_2024_2353331 crossref_primary_10_1093_toxsci_kfaa005 crossref_primary_10_1021_nn1013484 crossref_primary_10_1021_ci100176x crossref_primary_10_1186_1471_2105_12_112 crossref_primary_10_1177_02698811231187127 crossref_primary_10_4018_IJQSPR_2018010101 crossref_primary_10_1016_j_crtox_2023_100108 crossref_primary_10_1021_acs_chemrestox_0c00423 crossref_primary_10_30699_ijmm_18_3_135 crossref_primary_10_1186_s12910_015_0024_x crossref_primary_10_1038_nrgastro_2011_22 crossref_primary_10_1186_s12967_019_1976_2 crossref_primary_10_1039_C7RA12957B crossref_primary_10_1016_j_heliyon_2023_e21894 crossref_primary_10_1051_bioconf_202413501004 crossref_primary_10_3390_microorganisms11061608 crossref_primary_10_1016_j_jhazmat_2022_129193 crossref_primary_10_4155_fmc_10_194 crossref_primary_10_1021_acs_chemrestox_4c00015 crossref_primary_10_1021_acs_chemrestox_8b00054 crossref_primary_10_3389_fphar_2016_00442 crossref_primary_10_1002_minf_201100005 crossref_primary_10_1021_acs_jmedchem_5b00104 crossref_primary_10_1021_acs_molpharmaceut_8b01048 crossref_primary_10_1021_ci400460q crossref_primary_10_1038_srep46277 crossref_primary_10_1002_minf_201600143 crossref_primary_10_1038_s41598_025_86016_9 crossref_primary_10_3390_ijtm3020013 crossref_primary_10_1021_ci300146h crossref_primary_10_1021_ci300421n crossref_primary_10_2217_pme_11_89 crossref_primary_10_1016_j_comtox_2020_100133 crossref_primary_10_1002_minf_201500055 crossref_primary_10_1021_tx100412m crossref_primary_10_1002_jat_2879 crossref_primary_10_1080_00268976_2024_2436095 crossref_primary_10_3109_17435390_2015_1073397 crossref_primary_10_1515_zpch_2023_0397 crossref_primary_10_1021_acs_chemrev_6b00851 crossref_primary_10_1371_journal_pcbi_1002310 crossref_primary_10_1007_s10822_011_9468_3 crossref_primary_10_1124_dmd_118_083055 crossref_primary_10_1517_17425255_2012_648613 crossref_primary_10_1140_epjp_s13360_024_05900_x crossref_primary_10_1111_bph_13207 crossref_primary_10_1007_s10822_016_9972_6 crossref_primary_10_1177_026119291604400407 crossref_primary_10_1016_j_ijbiomac_2025_141273 crossref_primary_10_1177_026119291504300112 crossref_primary_10_1186_s13321_017_0230_2 crossref_primary_10_1002_minf_201200119 crossref_primary_10_1186_1479_5876_10_217 crossref_primary_10_1080_17425255_2017_1316449 crossref_primary_10_1021_acs_molpharmaceut_5b00583 crossref_primary_10_1021_acs_jcim_3c00200 crossref_primary_10_1016_j_tox_2017_06_003 crossref_primary_10_1016_j_compchemeng_2025_109066 crossref_primary_10_1016_j_drudis_2011_05_007 crossref_primary_10_1016_j_jhazmat_2024_134297 crossref_primary_10_1007_s40203_025_00324_6 crossref_primary_10_1002_minf_201400188 crossref_primary_10_1021_acs_jcim_6b00277 crossref_primary_10_1177_15353702231209421 crossref_primary_10_1007_s10989_016_9564_2 crossref_primary_10_3390_ijms20081897 crossref_primary_10_1111_cbdd_14607 crossref_primary_10_3109_10408444_2013_811215 crossref_primary_10_1186_1472_6939_13_16 crossref_primary_10_1021_ci300367a crossref_primary_10_1007_s00204_015_1618_2 crossref_primary_10_1080_1062936X_2016_1264468 crossref_primary_10_1093_toxsci_kfx099 crossref_primary_10_1016_j_vascn_2013_12_003 crossref_primary_10_1155_2021_2293871 crossref_primary_10_3390_molecules25030481 crossref_primary_10_1002_wcms_100 crossref_primary_10_1177_026119291304100504 crossref_primary_10_3109_03602532_2011_605791 crossref_primary_10_1016_j_chphi_2024_100784 crossref_primary_10_1039_c3ra40787j crossref_primary_10_1016_j_comtox_2021_100187 crossref_primary_10_1002_minf_201000061 crossref_primary_10_1039_D0CS00098A crossref_primary_10_1124_dmd_110_035113 crossref_primary_10_1016_j_tox_2014_03_009 crossref_primary_10_1177_1535370214531872 crossref_primary_10_1080_1062936X_2016_1201142 crossref_primary_10_2217_bmm_13_146 crossref_primary_10_1177_026119291404200306 crossref_primary_10_1155_2020_4795140 crossref_primary_10_1126_scitranslmed_3000890 crossref_primary_10_1021_acs_chemrestox_5b00465 crossref_primary_10_1080_10406638_2023_2239984 crossref_primary_10_1002_adfm_201909553  | 
    
| Cites_doi | 10.1016/S0168-8278(97)80494-1 10.1006/rtph.2000.1399 10.1016/j.taap.2008.01.037 10.2174/138620708785739907 10.1016/j.cbpa.2006.06.023 10.1016/S0378-4274(98)00261-6 10.1016/j.ddtec.2004.11.002 10.1093/toxsci/kfn109 10.1021/ci700443v 10.2174/138161207782794257 10.1021/tx600260a 10.1016/j.jmgm.2004.03.009 10.1007/978-1-4757-3264-1 10.1007/s10822-005-9008-0 10.1002/qsar.200810084 10.2174/1389200053586118 10.1023/B:JCAM.0000021834.50768.c6 10.1021/ci800151m 10.1177/009286150103500134 10.1016/j.toxlet.2008.09.017 10.1086/381446 10.2174/157340908785747465 10.1002/jcc.20812 10.1080/07366290601067481 10.1002/hep.21095 10.1007/s00204-006-0091-3  | 
    
| ContentType | Journal Article | 
    
| Copyright | Copyright © 2009 American Chemical Society | 
    
| Copyright_xml | – notice: Copyright © 2009 American Chemical Society | 
    
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM  | 
    
| DOI | 10.1021/tx900326k | 
    
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles)  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology  | 
    
| DocumentTitleAlternate | Cheminformatics Analysis of Assertions Mined from Literature | 
    
| EISSN | 1520-5010 | 
    
| EndPage | 183 | 
    
| ExternalDocumentID | PMC2850112 20014752 10_1021_tx900326k d083852940  | 
    
| Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural  | 
    
| GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R21 GM076059 – fundername: NIGMS NIH HHS grantid: R21GM076059  | 
    
| GroupedDBID | - 29B 4.4 55A 5GY 5RE 5VS 7~N AABXI ABFLS ABMVS ABPTK ABUCX ACGFS ACJ ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 EBS ED ED~ EJD F5P GNL IH9 IHE JG JG~ LG6 P2P ROL TN5 UI2 UPT VF5 VG9 W1F X YZZ --- -~X AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV AGXLV AHGAQ CITATION CUPRZ GGK .GJ .HR 1WB 53G ABHMW ACRPL ADNMO AEYZD AGQPQ ANPPW ANTXH CGR CUY CVF ECM EIF NPM RNS ZGI 7X8 5PM  | 
    
| ID | FETCH-LOGICAL-a369t-7a7844849c12dc6198674c7906693bf8c776fe83a0c7bd052622c69dc0144fc93 | 
    
| IEDL.DBID | ACS | 
    
| ISSN | 0893-228X 1520-5010  | 
    
| IngestDate | Thu Aug 21 13:56:10 EDT 2025 Wed Oct 01 17:19:30 EDT 2025 Mon Jul 21 06:01:19 EDT 2025 Tue Jul 01 03:45:16 EDT 2025 Thu Apr 24 22:51:24 EDT 2025 Thu Aug 27 13:41:55 EDT 2020  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 1 | 
    
| Language | English | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-a369t-7a7844849c12dc6198674c7906693bf8c776fe83a0c7bd052622c69dc0144fc93 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23  | 
    
| PMID | 20014752 | 
    
| PQID | 733805344 | 
    
| PQPubID | 23479 | 
    
| PageCount | 13 | 
    
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2850112 proquest_miscellaneous_733805344 pubmed_primary_20014752 crossref_primary_10_1021_tx900326k crossref_citationtrail_10_1021_tx900326k acs_journals_10_1021_tx900326k  | 
    
| ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ACS AEESW AFEFF ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2010-01-01 | 
    
| PublicationDateYYYYMMDD | 2010-01-01 | 
    
| PublicationDate_xml | – month: 01 year: 2010 text: 2010-01-01 day: 01  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | United States | 
    
| PublicationPlace_xml | – name: United States | 
    
| PublicationTitle | Chemical research in toxicology | 
    
| PublicationTitleAlternate | Chem. Res. Toxicol | 
    
| PublicationYear | 2010 | 
    
| Publisher | American Chemical Society | 
    
| Publisher_xml | – name: American Chemical Society | 
    
| References | Farkas D. (ref8/cit8) 2005; 6 Sutter W. (ref7/cit7) 2006; 10 Elferink M. G. (ref12/cit12) 2008; 229 O’Brien P. J. (ref4/cit4) 2006; 80 Olson H. (ref28/cit28) 2000; 32 Egan W. (ref3/cit3) 2004; 1 Olson H. (ref27/cit27) 1998; 102 Varnek D. (ref19/cit19) 2006; 19 Varnek A. (ref24/cit24) 2007; 25 ref23/cit23 Zhu H. (ref32/cit32) 2008; 48 Olson H. (ref17/cit17) 2000; 32 Varnek A. (ref20/cit20) 2008; 4 Cruz-Monteagudo M. (ref16/cit16) 2008; 29 Ballet F. (ref6/cit6) 1997; 26 Xu J. J. (ref10/cit10) 2008; 105 Kaplowitz N. (ref5/cit5) 2004; 38 Elferink M. (ref9/cit9) 2008; 229 Meier P. (ref31/cit31) 1990; 120 Watkins P. (ref2/cit2) 2006; 43 ref15/cit15 Todeschini R. (ref30/cit30) 2006 Tetko I. V. (ref33/cit33) 2008; 48 Downs G. (ref22/cit22) 2002; 18 Fung M. (ref1/cit1) 2009; 35 Blomme E. A. (ref11/cit11) 2009; 186 Young D. (ref18/cit18) 2008; 27 Clark R. (ref14/cit14) 2004; 22 Baskin I. (ref21/cit21) 2008; 11 Guengerich F. P. (ref29/cit29) 2007; 20 Vapnik V. N. (ref25/cit25) 2000 Cheng A. (ref13/cit13) 2003; 17 Tropsha A. (ref26/cit26) 2007; 13  | 
    
| References_xml | – volume: 26 start-page: 26 issue: 2 year: 1997 ident: ref6/cit6 publication-title: J. Hepatol. doi: 10.1016/S0168-8278(97)80494-1 – volume: 32 start-page: 56 year: 2000 ident: ref17/cit17 publication-title: Regul. Toxicol. Pharmacol. doi: 10.1006/rtph.2000.1399 – volume: 229 start-page: 300 issue: 3 year: 2008 ident: ref12/cit12 publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2008.01.037 – volume: 11 start-page: 661 issue: 8 year: 2008 ident: ref21/cit21 publication-title: Comb. Chem. High Throughput Screening doi: 10.2174/138620708785739907 – volume: 10 start-page: 362 issue: 4 year: 2006 ident: ref7/cit7 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2006.06.023 – volume: 102 start-page: 535 year: 1998 ident: ref27/cit27 publication-title: Toxicol. Lett. doi: 10.1016/S0378-4274(98)00261-6 – volume: 1 start-page: 381 issue: 4 year: 2004 ident: ref3/cit3 publication-title: Drug Discovery Today: Technol. doi: 10.1016/j.ddtec.2004.11.002 – volume-title: DRAGON for Windows (Software for Molecular Descriptor Calculations) year: 2006 ident: ref30/cit30 – volume: 105 start-page: 97 issue: 1 year: 2008 ident: ref10/cit10 publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfn109 – volume: 48 start-page: 766 issue: 4 year: 2008 ident: ref32/cit32 publication-title: J. Chem. Inf. Model. doi: 10.1021/ci700443v – volume: 13 start-page: 3494 year: 2007 ident: ref26/cit26 publication-title: Curr. Pharm. Des. doi: 10.2174/138161207782794257 – volume: 20 start-page: 344 issue: 3 year: 2007 ident: ref29/cit29 publication-title: Chem. Res. Toxicol. doi: 10.1021/tx600260a – volume: 22 start-page: 487 year: 2004 ident: ref14/cit14 publication-title: J. Mol. Graphics Modell. doi: 10.1016/j.jmgm.2004.03.009 – volume-title: The Nature of Statistical Learning Theory year: 2000 ident: ref25/cit25 doi: 10.1007/978-1-4757-3264-1 – ident: ref23/cit23 – volume: 19 start-page: 693 year: 2006 ident: ref19/cit19 publication-title: J. Comput.-Aided Mol. Des. doi: 10.1007/s10822-005-9008-0 – volume: 27 start-page: 1337 year: 2008 ident: ref18/cit18 publication-title: QSAR Comb. Sci. doi: 10.1002/qsar.200810084 – volume: 120 start-page: 221 issue: 7 year: 1990 ident: ref31/cit31 publication-title: Schweiz. Med. Wochenschr. – volume: 6 start-page: 111 issue: 2 year: 2005 ident: ref8/cit8 publication-title: Curr. Drug Metab. doi: 10.2174/1389200053586118 – volume: 32 start-page: 56 issue: 1 year: 2000 ident: ref28/cit28 publication-title: Regul. Toxicol. Pharmacol. doi: 10.1006/rtph.2000.1399 – volume: 17 start-page: 811 year: 2003 ident: ref13/cit13 publication-title: J. Comput.-Aided Mol. Des. doi: 10.1023/B:JCAM.0000021834.50768.c6 – volume: 48 start-page: 1733 issue: 9 year: 2008 ident: ref33/cit33 publication-title: J. Chem. Inf. Model. doi: 10.1021/ci800151m – volume: 35 start-page: 293 year: 2009 ident: ref1/cit1 publication-title: Drug. Inf. J. doi: 10.1177/009286150103500134 – volume: 186 start-page: 22 issue: 1 year: 2009 ident: ref11/cit11 publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2008.09.017 – volume: 38 start-page: S44 issue: 2 year: 2004 ident: ref5/cit5 publication-title: Clin. Infect. Dis. doi: 10.1086/381446 – volume: 229 start-page: 300 year: 2008 ident: ref9/cit9 publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2008.01.037 – volume: 4 start-page: 191 issue: 3 year: 2008 ident: ref20/cit20 publication-title: Curr. Comput.-Aided Drug Des. doi: 10.2174/157340908785747465 – ident: ref15/cit15 – volume: 29 start-page: 533 issue: 4 year: 2008 ident: ref16/cit16 publication-title: J. Comput. Chem. doi: 10.1002/jcc.20812 – volume: 25 start-page: 1 issue: 1 year: 2007 ident: ref24/cit24 publication-title: Solvent Extr. Ion Exch. doi: 10.1080/07366290601067481 – volume: 43 start-page: 618 issue: 3 year: 2006 ident: ref2/cit2 publication-title: Hepatology doi: 10.1002/hep.21095 – volume: 80 start-page: 580 issue: 9 year: 2006 ident: ref4/cit4 publication-title: Arch. Toxicol. doi: 10.1007/s00204-006-0091-3 – volume: 18 start-page: 1 year: 2002 ident: ref22/cit22 publication-title: Rev. Comp. Chem.  | 
    
| SSID | ssj0011027 | 
    
| Score | 2.3599358 | 
    
| Snippet | Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical... Drug Induced Liver Injury (DILI) is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical...  | 
    
| SourceID | pubmedcentral proquest pubmed crossref acs  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 171 | 
    
| SubjectTerms | Animals Chemical and Drug Induced Liver Injury Cluster Analysis Databases, Factual Humans MEDLINE Mice Models, Chemical Molecular Conformation Quantitative Structure-Activity Relationship  | 
    
| Title | Cheminformatics Analysis of Assertions Mined from Literature That Describe Drug-Induced Liver Injury in Different Species | 
    
| URI | http://dx.doi.org/10.1021/tx900326k https://www.ncbi.nlm.nih.gov/pubmed/20014752 https://www.proquest.com/docview/733805344 https://pubmed.ncbi.nlm.nih.gov/PMC2850112  | 
    
| Volume | 23 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVABC databaseName: American Chemical Society Journals customDbUrl: eissn: 1520-5010 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011027 issn: 0893-228X databaseCode: ACS dateStart: 19880101 isFulltext: true titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals providerName: American Chemical Society  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fT9wwDLYYe5k0bYz9um0ga5vQHgjj0jRpHk_cEJtgQgKke6vSNGWMqYdoT9rx1-M0beEG257rpkpjJ59j-zPAx8ZFtjpn2mSaCRU5lm0byzxPSxGTpcumfdvBd7l3Ir5N4skSfPhLBJ8PP9e__WUbl-cP4CGXSvm8vdHOUR8qIKFA56kjxnky6eiDbr_qjx5bLR49d_Dkn2mRt86Z3acw7qp1QnrJ-daszrbs1V3yxn9NYQWetDgTR0ExnsGSK1dh4zAQVc838fim7qraxA08vKGwnq_C43Cbh6FI6TnMG16BsgW4tsKOywSnBY6aiL5XXzwgzJqjL1nB_Z6vmb5laiQHlzaozOH4cnbKfMcQS6L7Pi0Ev5Y_aWnxrMRx26-lxqMLR9tO9QJOdr8c7-yxtmkDM5HUNVNGJeTyCW2HPLfkniVSCas0QRsdZUVilZKFSyKzbVWWe7YZzq3UufWuXWF19BKWy2npXgOKhLCb0TZOIidyLk2RGUkOJA1MX4mGA1inVU1bo6vSJp7Oh2n_uwfwqVvw1LaU577zxq_7RN_3oheB5-M-Iey0JiUr9KEVU7rprEoVefq0nQkxgFdBifpRfNKaUDEfgFpQr17AE3wvPinPfjRE3zyJ_Wzf_G-eb-FRSGrwN0PvYLm-nLk1wkp1tt7YyjU4Nw_y | 
    
| linkProvider | American Chemical Society | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdgPICE-BiMlY9xQmjiYR6L49jxY7UxddBOk9ZJfYscx4GxKZ2WVKL89ZztNF3HJHjOxZ939p3v7neEfPQmslEFVTpXlMvY0nxPG-pwWsoEJV348m2jYzE4418nyaSFyXG5MDiIGluqvRN_iS4QfW5-uTc3Ji7ukweJ4JEztPr7p53HAIkCqqeKKWPpZIEidPNXdwOZevUG-kutvB0deeO6OXwa6hb5gfook4vdWZPvmt-3MBz_bybPyJNW64R-YJPn5J6t1sn2SYCtnu_AeJmFVe_ANpwsAa3n6-RxeNuDkLL0gsw9ykDVqrumhgWyCUxL6Hv_vmNmGKEGW4BLYIFhh96MfekG0NzF4yq3cHA9-05d_RCDpEMXJAJH1U_caDiv4KCt3tLA6ZXFQ6h-Sc4Ov4z3B7Qt4UB1LFRDpZYpGoBcmYgVBo21VEhupEJFR8V5mRopRWnTWO8ZmRcOe4YxI1RhnKFXGhVvkLVqWtlNAjxFTU4rk6Sx5QUTusy1QHMSG8Ze4qhHtnC1s1YE68x711mUdcvdI58W-56ZFgDd1eG4vIv0Q0d6FVA_7iKCBfNkKJPO0aIrO53VmUS7Hw83znvkVeClrhUXwsZlwnpErnBZR-Dgvle_VOc_POw3SxM329f_mud78nAwHg2z4dHxtzfkUQh3cG9Gb8lacz2z71CLavItLz5_AOdxGFQ | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwED_BkBAS4jFe5TFOCE18mMfqOHb8cVqpNuhGpW1Sv0WO48AYSqsllSh_PWcnzdYxCT7n4uedfee7-x3A-2AiW50zbTLNhIocy3aMZR6npYhJ0mUo33Z4JPdPxedJPGkNRZ8LQ4OoqKUqOPG9VM_yokUY6H-sf_l3Ny7Pb8OdWJKIe1Vo77jzGhBRg-ypI8Z5MlkiCV391d9Ctlq9hf5SLa9HSF65coYP4Ws32BBpcr49r7Nt-_sajuP_z-YRPGi1T9xt2OUx3HLlOmyOG_jqxRaeXGZjVVu4ieNLYOvFOtxv3viwSV16AouANlC2aq-tcIlwgtMCd4Of3zM1HpImm6NPZMFRh-JMfZkayeylYytzOLiYf2O-jogl0pEPFsGD8gdtOJ6VOGiruNR4PHN0GFVP4XT46WRvn7WlHJiJpK6ZMiohQ1Bo2-e5JaMtkUpYpUnh0VFWJFYpWbgkMjtWZbnHoOHcSp1bb_AVVkfPYK2clu4FoEhIozPaxknkRM6lKTIjyaykhqmXqN-DDVrxtBXFKg1edt5Pu-XuwYfl3qe2BUL39Th-3kT6riOdNegfNxHhkoFSkk3vcDGlm86rVJH9T4ecED143vBT14oPZRMq5j1QK5zWEXjY79Uv5dn3AP_Nk9jP9uW_5vkW7o4Hw3R0cPTlFdxroh7809FrWKsv5u4NKVN1thEk6A_kCBrX | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cheminformatics+analysis+of+assertions+mined+from+literature+that+describe+drug-induced+liver+injury+in+different+species&rft.jtitle=Chemical+research+in+toxicology&rft.au=Fourches%2C+Denis&rft.au=Barnes%2C+Julie+C&rft.au=Day%2C+Nicola+C&rft.au=Bradley%2C+Paul&rft.date=2010-01-01&rft.issn=1520-5010&rft.eissn=1520-5010&rft.volume=23&rft.issue=1&rft.spage=171&rft_id=info:doi/10.1021%2Ftx900326k&rft.externalDBID=NO_FULL_TEXT | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-228X&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-228X&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-228X&client=summon |